These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 23834755

  • 1. Effect of CCL5 on dimethylarginine dimethylaminohydrolase-1 production in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY, Kim JH, Kim HS.
    Cytokine; 2013 Oct; 64(1):227-33. PubMed ID: 23834755
    [Abstract] [Full Text] [Related]

  • 2. CCL5 upregulates activation of AMP-activated protein kinases in vascular smooth muscle cells of spontaneously hypertensive rats.
    Kim HY, Cha HJ, Kim HS.
    Cytokine; 2014 Jun; 67(2):77-84. PubMed ID: 24656927
    [Abstract] [Full Text] [Related]

  • 3. Sulfatase 1 mediates the attenuation of Ang II-induced hypertensive effects by CCL5 in vascular smooth muscle cells from spontaneously hypertensive rats.
    Cha HJ, Kim HY, Kim HS.
    Cytokine; 2018 Oct; 110():1-8. PubMed ID: 29684635
    [Abstract] [Full Text] [Related]

  • 4. Dimethylarginine dimethylaminohydrolase-1 mediates inhibitory effect of interleukin-10 on angiotensin II-induced hypertensive effects in vascular smooth muscle cells of spontaneously hypertensive rats.
    Kim HY, Kim HS.
    Cytokine; 2016 Jan; 77():203-10. PubMed ID: 26375520
    [Abstract] [Full Text] [Related]

  • 5. CCL5 upregulates IL-10 expression and partially mediates the antihypertensive effects of IL-10 in the vascular smooth muscle cells of spontaneously hypertensive rats.
    Kim HY, Cha HJ, Kim HS.
    Hypertens Res; 2015 Oct; 38(10):666-74. PubMed ID: 25971630
    [Abstract] [Full Text] [Related]

  • 6. Angiotensin II inhibits chemokine CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats.
    Yun YH, Kim HY, Do BS, Kim HS.
    Hypertens Res; 2011 Dec; 34(12):1313-20. PubMed ID: 21814216
    [Abstract] [Full Text] [Related]

  • 7. IL-10 up-regulates CCL5 expression in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY, Kim HS.
    Cytokine; 2014 Jul; 68(1):40-9. PubMed ID: 24656930
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 12-lipoxygenase expression in vascular smooth muscle cells from old normotensive Wistar-Kyoto rats with spontaneously hypertensive rats.
    Kim HY, Jeong DW, Park HS, Lee TY, Kim HS.
    Hypertens Res; 2013 Jan; 36(1):65-73. PubMed ID: 22875070
    [Abstract] [Full Text] [Related]

  • 9. Sulfatase 1 mediates IL-10-induced dimethylarginine dimethylaminohydrolase-1 expression and antiproliferative effects in vascular smooth muscle cells of spontaneously hypertensive rats.
    Kim HY, Kim HS.
    Cytokine; 2021 Jan; 137():155344. PubMed ID: 33128921
    [Abstract] [Full Text] [Related]

  • 10. Hypertensive effects of transforming growth factor-β1 in vascular smooth muscles cells from spontaneously hypertensive rats are mediated by sulfatase 2.
    Kim HS, Kim HY.
    Cytokine; 2022 Feb; 150():155754. PubMed ID: 34808537
    [Abstract] [Full Text] [Related]

  • 11. Vascular smooth muscle cell NAD(P)H oxidase activity during the development of hypertension: Effect of angiotensin II and role of insulinlike growth factor-1 receptor transactivation.
    Cruzado MC, Risler NR, Miatello RM, Yao G, Schiffrin EL, Touyz RM.
    Am J Hypertens; 2005 Jan; 18(1):81-7. PubMed ID: 15691621
    [Abstract] [Full Text] [Related]

  • 12. [Effects of angiotensin II on extracellular signal-regulated protein kinases signaling pathway in cultured vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats].
    Zhu JH, Liu Z, Huang ZY, Li S.
    Sheng Li Xue Bao; 2005 Oct 25; 57(5):587-92. PubMed ID: 16220196
    [Abstract] [Full Text] [Related]

  • 13. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 25; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 14. Different calcium storage pools in vascular smooth muscle cells from spontaneously hypertensive and normotensive Wistar-Kyoto rats.
    Neusser M, Tepel M, Golinski P, Holthues J, Spieker C, Zhu Z, Zidek W.
    J Hypertens; 1994 May 25; 12(5):533-8. PubMed ID: 7930553
    [Abstract] [Full Text] [Related]

  • 15. Early regression of coronary artery remodeling with esmolol and DDAH/ADMA pathway in hypertensive rats.
    Quintana-Villamandos B, Arnalich-Montiel A, Arribas S, Lüneburg N, Böger RH, Delgado-Martos MJ, Fernández-Criado C, Delgado-Baeza E, González MC.
    Hypertens Res; 2016 Oct 25; 39(10):692-700. PubMed ID: 27250567
    [Abstract] [Full Text] [Related]

  • 16. Differential regulation of Nox1, Nox2 and Nox4 in vascular smooth muscle cells from WKY and SHR.
    Briones AM, Tabet F, Callera GE, Montezano AC, Yogi A, He Y, Quinn MT, Salaices M, Touyz RM.
    J Am Soc Hypertens; 2011 Oct 25; 5(3):137-53. PubMed ID: 21419746
    [Abstract] [Full Text] [Related]

  • 17. Role of complement 3a in the synthetic phenotype and angiotensin II-production in vascular smooth muscle cells from spontaneously hypertensive rats.
    Han Y, Fukuda N, Ueno T, Endo M, Ikeda K, Xueli Z, Matsumoto T, Soma M, Matsumoto K.
    Am J Hypertens; 2012 Mar 25; 25(3):284-9. PubMed ID: 22089112
    [Abstract] [Full Text] [Related]

  • 18. Sulfatase 2 mediates, partially, the expression of endothelin-1 and the additive effect of Ang II-induced endothelin-1 expression by CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY, Jeong DW, Kim HS.
    Cytokine; 2019 Feb 25; 114():98-105. PubMed ID: 30470661
    [Abstract] [Full Text] [Related]

  • 19. Upregulation of interleukin-8/CXCL8 in vascular smooth muscle cells from spontaneously hypertensive rats.
    Kim HY, Kang YJ, Song IH, Choi HC, Kim HS.
    Hypertens Res; 2008 Mar 25; 31(3):515-23. PubMed ID: 18497472
    [Abstract] [Full Text] [Related]

  • 20. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR.
    Tabet F, Schiffrin EL, Callera GE, He Y, Yao G, Ostman A, Kappert K, Tonks NK, Touyz RM.
    Circ Res; 2008 Jul 18; 103(2):149-58. PubMed ID: 18566342
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.